DUBLIN, Mar. 03, 2015 \/PRNewswire\/ --Research and Markets <\/p>\n
(http:\/\/www.researchandmarkets.com\/research\/rcv4lq\/gene_therapy<\/a>) has announced the addition of the \"Gene Therapy Market, 2015 - 2025\" report to their offering. <\/p>\n The \"Gene Therapy Market, 2015-2025\" report provides an extensive study on the marketed and pipeline gene therapies. A lot of research has been carried out in this field for over a decade but there are only five approved therapies (four available in Asian markets; one approved in the EU). There are many promising therapies which are currently being developed worldwide; the approach is likely to result in several commercial success stories in the foreseen future. The report covers various aspects, such as key players, marketed gene therapy products, products in clinical \/ pre-clinical research, associated ethical issues, likely future developments and upcoming opportunities for a variety of stakeholders. <\/p>\n Several disorders that arise inside the body are a result of either a direct genetic aberration or a dysfunctional\/non-functional protein. The attempt to use nucleic acids to correct or delete the genes causing a particular disease is known as gene therapy. Although gene therapy has not contributed significantly to the global pharmaceutical market yet, it is anticipated to grow at a fast pace over the next decade. <\/p>\n Gendicine, developed by SiBiono GeneTech, was the foremost gene therapy that entered market in 2004 in China. Since then four more therapies have received approval in China, Philippines, Russia and the EU. This number for approved \/ marketed therapies seems weak at present; however, the strong and highly populated pipeline holds tremendous potential. There are 12 gene therapies in late stage of clinical development for the treatment of cancer, ocular and cardiovascular disorders. <\/p>\n There are several concerns that remain to be answered; examples include insertional mutagenesis, treatment of multigene disorders, curbing the risk of immune reactions, eugenics, high cost of therapy and ethical concerns related to making alterations at the genetic level. Despite this, gene therapy does offer a ray of hope for patients who either have no treatment options or show no benefits with drugs that are currently available. Such a benefit far outweighs any disadvantages that may be associated with this upcoming therapeutic field. <\/p>\n Key Topics Covered: <\/p>\n 1. Preface <\/p>\n 2. Executive Summary <\/p>\n 3. Introduction <\/p>\n <\/p>\n Go here to see the original: <\/p>\n Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" DUBLIN, Mar. 03, 2015 \/PRNewswire\/ --Research and Markets (http:\/\/www.researchandmarkets.com\/research\/rcv4lq\/gene_therapy<\/a>) has announced the addition of the \"Gene Therapy Market, 2015 - 2025\" report to their offering. The \"Gene Therapy Market, 2015-2025\" report provides an extensive study on the marketed and pipeline gene therapies. Continue reading